Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Dr. McFarland To Provide Clinical Update on trial - June 27

<< Previous

Bullboard Posts

Next >>

Comment by Mongoose1975on Mar 31, 2022 12:24pm

231 Views

Post# 34563392

RE:Dr. McFarland To Provide Clinical Update on trial - June 27

If Sherri McFarland is making a Clinical Update at a conference June 27th. I imagine it's a good, scratch that....Excellent update because no one is going to speak at a conference if it's not. I also imagine we are going to get news long before that as I can't see her going up and saying "well it's a great therapy but we are still waiting for BTD" IMO

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?